175 results
8-K
EX-4.1
ZIVO
ZIVO Bioscience, Inc.
22 Nov 23
Entry into a Material Definitive Agreement
4:21pm
, specifying the nature and status of the Event of Default or other event or of such demand or action, as the case may be.
ARTICLE IV
REMEDIES
SECTION 4.1
8-K
EX-10.1
ZIVO
ZIVO Bioscience, Inc.
22 Nov 23
Entry into a Material Definitive Agreement
4:21pm
, recommendation or other statement of any kind or nature with respect to the anticipated profits or losses of the Company, except as otherwise provided
D
uwdil8hxr4ntlhg2
17 Jul 23
$4.00 mm in options / securities to be acquired, sold $4.00 mm, 1 investor
4:07pm
8-K
gixkxq1lvw90rdcfde
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
8-K
EX-1.1
zuyew8q0izvzgny
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
8-K
EX-10.1
0djhu814 yfp4
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
424B5
6jyf2v4muxs
5 Jul 23
Prospectus supplement for primary offering
7:21am
8-K
EX-10.1
cm0nrox1cszul9cmv
5 Apr 23
ZIVO Bioscience Receives $1 Million Bridge Financing
4:15pm
8-K
EX-4.1
ovpkz8w
5 Apr 23
ZIVO Bioscience Receives $1 Million Bridge Financing
4:15pm
8-K
EX-3.1
9ifl20 usgjnsa3o
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:33pm